Corrigendum: Linking the Declarations of Helsinki and of Taipei: Critical Challenges of Future-Oriented Research Ethics

Frontiers in Pharmacology

卷:11

Sandor Kerpel-Fronius¹  Kotone Matsuyama²  Luís Filipe Laranjeira³  Shehla Naseem⁴  Johanna Schenk⁵  Honorio Silva⁶  on behalf of Working Group on Ethics of the International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine⁷  Peter Kleist⁸  Sander Becker⁹  Luis Francisco Collia¹⁰  Brigitte Franke-Bray¹¹  Varvara Baroutsou¹²  Roberto Carlesi¹³  Johan Brun¹⁴  Chieko Kurihara¹⁵  Anthony Chan¹⁶ 

[1] Co. KG, Hochheim am Main, Germany;

[2] Co., Lisbon, Portugal;

[3] 0Eli Lilly &

[4] 1Nippon Medical School, Tokyo, Japan;

[5] 2Ferozsons Laboratories Ltd, Karachi, Pakistan;

[6] 3PPH Plus GmbH &

[7] 4IFAPP Academy, New York, NY, United States;

[8] Cantonal Ethics Committee, Zurich, Switzerland;

[9] Consultants in Pharmaceutical Medicine, Dover Heights, Australia;

[10] Craveri Pharma, Buenos Aires, Argentina;

[11] Independent Consultant, Basel, Switzerland;

[12] Independent Medical Consultant, and Consultant, Pharmaceutical Medicine, Athens, Greece;

[13] Independent Researcher, Bellagio, Italy;

[14] LIF, Stockholm, Sweden;

[15] National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan;

[16] Pfizer Biopharmaceuticals Group, Dublin, Ireland;

关键词: research ethics;    data science;    medicines development;    privacy protection;    data sharing;    declaration of Helsinki;   

DOI  :  10.3389/fphar.2020.637775

来源: DOAJ

【 授权许可】

Unknown